21/03/2012 — INDIANAPOLIS & ZÜRICH — (BUSINESS WIRE)

Dow AgroSciences LLC, a wholly owned subsidiary of The Dow Chemical
Company (NYSE: DOW), and Dualsystems Biotech announced today, a drug
profiling agreement. Under the agreement, Dualsystems Biotech will use
its drug profiling platform to identify molecular targets for an
undisclosed small molecule lead candidate in Dow AgroSciences’
agrochemical discovery program. Dualsystems Biotech as a partner will
contribute to the identification of new targets and elucidation of the
mechanism of action of a novel class of compounds.

Dualsystems exploits the versatility of its platform technology by
continuously expanding its international client base into all sectors of
the life science industry.

“Dow AgroSciences is pleased to announce this new partnership with
Dualsystems, an innovative leader in custom screening services,” said
Vidyadhar B. Hegde, Ph.D., Director, Chemistry, Discovery Research, Dow
AgroSciences. “This collaboration further expands our technology
tool-box to accelerate the progress of Discovery efforts to develop
novel solutions to meet the growing demands of our customers around the
world.”

“As we offer our superior services in a highly competitive research area
we are proud to have won this agreement from a prominent leader such as
Dow AgroSciences,” said Daniel Auerbach, CEO – Operations, Dualsystems
Biotech.

About Dualsystems Biotech AG

Dualsystems Biotech is a privately held biotechnology company
established in 2006 as a spin-off from the University Zurich,
Switzerland. Dualsystems has positioned itself as a leading provider of
screening services to the international research community in the
pharmaceutical, biotech, agrochemical and cosmetic industries as well as
academia.

Dualsystems Biotech’s unique and comprehensive screening platforms
enable the identification of small molecule-protein and protein-protein
interactions in any cellular setting. Dualsystems Biotech’s drug and
target profiling technologies have significant advantages in cost, speed
and sensitivity compared to similar screening technologies for small
molecules currently available. They are a powerful tool to accelerate
drug target discovery and elucidation of mechanism of action and
off-target effect identification in key therapeutic areas.

For more information about Dualsystems Biotech please visit http://www.dualsystems.com/
or http://www.drug-profiling.com

About Dow AgroSciences

Dow AgroSciences, based in Indianapolis, Indiana, USA, develops
leading-edge crop protection and plant biotechnology solutions to meet
the challenges of the growing world. Dow AgroSciences is a wholly owned
subsidiary of The Dow Chemical Company and had annual global sales of
$5.7 billion in 2011. Learn more at www.dowagro.com.
Follow Dow AgroSciences on Facebook
and YouTube
or subscribe to our News
Release RSS Feed.

CONTACT:

Dow AgroSciences
Robyn Heine, 317-337-4807
rheine@dow.com
or
Dualsystems
Biotech AG
Dr. Andreas J. Schulze, +41 44 738 50 01
Fax: +41
44 738 50 05
andreas.schulze@dualsystems.com

KEYWORDS: United States Europe North America Indiana Germany

INDUSTRY KEYWORDS: Natural Resources Agriculture Other Natural Resources Research Other Science Science

MEDIA: